Concepedia

Mark Peek

MP

Statistics

Publications

10

Citations

550

H-Index

10

Active since

1999

Affiliations

PDL BioPharma (United States)(Current)

Gene Therapy Laboratory

Genesys (United States)

Mark Peek is an author at PDL BioPharma (United States) specializing in biochemistry, life sciences, and molecular biology.

Publications per year

1999–2017

10

Publications

10

Hepsin activates pro‐hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor‐1B (HAI‐1B) and HAI‐2

Daniel Kirchhofer, Mark Peek, Michael T. Lipari et al. · FEBS Letters · 2005 · 158 citations

, , +10

Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1

Daniel Kirchhofer, Mark Peek, Wei Li et al. · Journal of Biological Chemistry · 2003 · 107 citations · Full text

, , +13

Structural and Functional Basis of the Serine Protease-like Hepatocyte Growth Factor β-Chain in Met Binding and Signaling

Daniel Kirchhofer, Xiaoyi Yao, Mark Peek et al. · Journal of Biological Chemistry · 2004 · 87 citations · Full text

, , +12

Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor XIa

Mark Peek, Paul Moran, Nerissa Mendoza et al. · Journal of Biological Chemistry · 2002 · 70 citations · Full text

, , +11

The Tissue Factor Region That Interacts with Factor Xa in the Activation of Factor VII

Daniel Kirchhofer, Charles Eigenbrot, Michael T. Lipari et al. · Biochemistry · 2000 · 40 citations

, , +14

1–5 of 10